ArticleSage open pathology
Tenosynovial Giant Cell Tumours: A Clinicopathologic Study of a Case-Series.
Article in Sage open pathology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Tenosynovial giant cell tumours (TSGCT) are rare mesenchymal tumours that develop in joints, bursae and tendon sheaths. The aim of this study was to describe the epidemiological, clinical and histopathological aspects of this pathology in Togo. Methodology: This was a retrospective descriptive and analytical study of histologically confirmed cases of tenosynovial giant cell tumour from 1 January 2014 to 31 December 2023 in the Pathology Department of the Sylvanus Olympio Teaching Hospital in Lomé, Togo. Results: We identified 12 cases of tenosynovial giant cell tumours. We found 8 male subjects and 4 female subjects. The mean age of our patients was 24.2 ± 12.8 years. The tumour was located in the fingers in 9 cases (75%) and in the toes in 3 cases (25%). The mean time to diagnosis was 26.3 + 20.8 months. Pain and a palpable mass were the main symptoms. The nodular type was found in 7 cases (58.33%) and the diffuse type in 5 cases (41.67%). Conclusion: Tenosynovial giant cell tumour is a benign proliferative disorder of the synovium, the aetiopathogenesis of which remains undetermined.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.